Results of a multicenter, 8-week, parallel-group, randomized,double-blind, double-dummy, phase III clinical trial to evaluate the efficacy and tolerability of amlodipine maleate versus amlodipine besylate in Korean patients with mild to moderate hypertens

In this population, the efficacy and tolerability observed with amlodipine maleate were similar to those seen with amlodipine besylate.